ExodusPoint Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-17,244
| Closed | -$436K | – | 1437 |
|
|
2024
Q4 | $436K | Buy |
+17,244
| New | +$436K | ﹤0.01% | 1082 |
|
|
2024
Q3 | – | Sell |
-38,150
| Closed | -$1.41M | – | 1546 |
|
|
2024
Q2 | $1.41M | Buy |
+38,150
| New | +$1.41M | 0.01% | 793 |
|
|
2023
Q4 | – | Sell |
-26,434
| Closed | -$727K | – | 1463 |
|
|
2023
Q3 | $727K | Buy |
+26,434
| New | +$727K | 0.01% | 1051 |
|
|
2021
Q2 | – | Sell |
-135,552
| Closed | -$2.79M | – | 2322 |
|
|
2021
Q1 | $2.79M | Sell |
135,552
-35,039
| -21% | -$722K | 0.04% | 415 |
|
|
2020
Q4 | $2.99M | Buy |
+170,591
| New | +$2.99M | 0.03% | 368 |
|
|
2020
Q3 | – | Sell |
-58,415
| Closed | -$759K | – | 1734 |
|
|
2020
Q2 | $759K | Buy |
+58,415
| New | +$759K | 0.02% | 858 |
|